170837 ⎘
Detection or diagnosis of diseases; Immunology or allergic disorders Transplantation related diseases, e.g. graft versus host disease
DETECTING XENOTRANSPLANT ORGAN REJECTION
#2METHODS FOR DETECTING ANTI-PORCINE ANTIBODIES
#3METHODS RELATING TO DIAGNOSING STABILITY FOLLOWING RENAL TRANSPLANTATION
#4METHODS FOR PREDICTING AND TREATING CHRONIC LUNG ALLOGRAFT DYSFUNCTION
#5METHODS FOR IMPROVING OUTCOMES FOR HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS AT RISK FOR BRONCHIOLITIS OBLITERANS SYNDROME
#6METHOD FOR TRANSPLANT ORGAN HEALTH ASSESSMENT
#7METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION
#8SYSTEMS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC ORGAN REJECTION
#9Method for Detecting Acute Rejection, Defining Therapy and Monitoring Rejection Therapy
#10COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR TREATMENT OF GRAFT VERSUS HOST DISEASE
#11AFUCOSYLATION OF HLA-SPECIFIC IGG1 AS A POTENTIAL PREDICTOR OF ANTIBODY PATHOGENICITY IN KIDNEY TRANSPLANTATION
#12USE OF MICROVESICLE SIGNATURES IN THE IDENTIFICATION AND TREATMENT OF RENAL DISORDERS
#13METHODS FOR IMPROVING LUNG TRANSPLANTS
#14COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION
#15METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS
#16Cultured Thymus Tissue Transplantation Promotes Donor-Specific Tolerance to Allogeneic Solid Organ Transplants
#17CD83 AND ALLO- AND AUTOIMMUNE CONDITIONS
#18METHOD OF TREATING SEVERE GRAFT VERSUS HOST DISEASE
#19Lateral Flow Device for Allograft Rejection
#20Method for Using a Marker Set for Determining the Risk of Kidney Rejection
#21INTESTINAL MICROBIOTA AND GVHD
#22METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS
#23NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY
#24METHODS OF GRAFT VERSUS HOST DISEASE DIAGNOSIS
#25DIAGNOSIS AND TREATMENT OF PRIMARY GRAFT DYSFUNCTION FOLLOWING LUNG TRANSPLANT
#26USE OF ALARMINS AS BIOMARKERS FOR ASSESSING ISCHEMIA-REPERFUSION INJURY SEVERITY AFTER SOLID ORGAN TRANSPLANTATION
#27METHODS OF SELECTIVELY TARGETING CD6 HIGH CELLS AND DECREASING ACTIVITY OF TEFF CELLS
#28METHODS FOR THE DIAGNOSIS AND THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE
#29A COMPOSITION COMPRISING MESENCHYMAL PRECURSOR OR STEM CELLS AND THEIR USE
#30APTAMERS THAT TARGET CXCL9
#31NOVEL T CELLS AND THE USES THEREOF
#32COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHIOLITIS OBLITERANS
#33Therapeutic Substances, their Preparation and Diagnostic Procedure
#34T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF
#35Methods for Diagnosing and/or Predicting the Risk of Having an Acute Rejection (AR) in a Kidney Transplant Recipient
#36MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATION
#37NEW PROTEIN MARKERS OF RENAL DAMAGE
#38Biomarkers for graft-versus-host disease
#39IN VITRO METHOD FOR DETERMINING THE LIKELIHOOD OF OCCURRENCE OF AN ACUTE MICROVASCULAR REJECTION (AMVR) AGAINST A RENAL ALLOGRAFT IN AN INDIVIDUAL
#40METHODS FOR TREATING COSTIMULATION BLOCKADE RESISTANT REJECTION
#41Method for Evaluating Damage of Solid Tissue
#42Methods of preparing a biofluid sample for detection of kidney injury
#43METHODS FOR DETECTING, QUANTIFYING AND MONITORING IMMUNE-CELL MEDIATED CYTOTOXICITY OF CELL POPULATIONS COMPROMISING IMMUNE CELLS AND/OR STEM CELLS
#44Method for predicting and monitoring clinical response to immunomodulatory therapy
#45URINARY EXOSOME BIOMARKER FOR DIAGNOSING ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION OR PREDICTING PROGNOSIS OF PATIENT AFTER KIDNEY TRANSPLANTATION
#46NON-HLA MARKERS OF TRANSPLANT REJECTION
#47BIOMARKER FOR TRANSPLANTATION TOLERANCE INDUCED BY APOPTOTIC DONOR LEUKOCYTES
#48Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries
#49METHODS AND COMPOSITIONS FOR NONINVASIVE DETECTION OF ORGAN TRANSPLANT REJECTION
#50DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS
#51Urine metabolomics based method of detecting renal allograft injury
#52mRNA-BASED BIOMARKERS FOR ANTIBODY-MEDIATED TRANSPLANT REJECTION
#53Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#54USE OF SHROOM3 IN CHRONIC KIDNEY DISEASE AND CHRONIC ALLOGRAFT NEPHROPATHY
#55Compositions and methods for detection and treatment of coronavirus infection
#56Reagents for detecting Alu elements in cell-free DNA (cfDNA)
#57METHOD FOR INCREASING CELL SUSCEPTIBILITY TO COMPLEMENT- MEDIATED LYSIS
#58Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases
#59Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#60Anti-CXC chemokine receptor antibodies and C-X-C chemokines for the diagnosis of autoimmune disease and graft-versus-host disease
#61Methods and Compositions for Regulating an Immune Response
#62VITAMIN D BINDING PROTEIN IN THE CLINICAL MANAGEMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
#63Protein and gene biomarkers for rejection of organ transplants
#64METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF
#65THERAPEUTIC SUBSTANCES, THEIR PREPARATION AND DIAGNOSTIC PROCEDURE
#66BIOMARKERS FOR GRAFT-VERSUS-HOST DISEASE
#67Biomarkers for graft-versus-host disease
#68ANTIBODY SCREENS USING TRANSGENIC ANTIGEN(S)
#69METHOD FOR REGULATING ANTIGEN-SPECIFIC MHC EXPRESSION
#70Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#71TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTIONS
#72Biomarkers for Typing Allograft Recipients
#73Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
#74Systems and methods for diagnosing and treating chronic organ rejection
#75Modified Fc gamma receptor type III (FcgammaIII, HNA-1) polypeptides and the uses thereof
#76HLA G-MODIFIED CELLS AND METHODS
#77METHOD FOR PREDICTING ORGAN TRANSPLANT REJECTION USING NEXT-GENERATION SEQUENCING
#78BIOMARKERS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#79Method of diagnosing and treating acute rejection in kidney transplant patients
#80Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers
#81Methods for detecting sinusoidal obstructive syndrome (SOS)
#82METHOD FOR IN VITRO EARLY DIAGNOSIS OF ANTIBODY MEDIATED REJECTION AFTER ORGAN TRANSPLANTATION USING IgM-TYPE MEMORY B CELL DIFFERENTIATION CULTURE SYSTEM
#83METHODS FOR ASSESSING GRAFT FAILURE RISK
#84METHODS OF PREDICTING POST-TRANSFUSION SURVIVAL OF RED BLOOD CELLS
#85METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS
#86DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS
#87Kit for monitoring, detecting and staging GVHD
#88Materials and methods for subjects at risk for viral reactivation
#89Methods for treating costimulation blockade resistant rejection
#90COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES
#91HLA G-modified cells and methods
#92Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#93URINE FLOW CYTOMETRY AS BIOMARKER OF RENAL DISEASES
#94Exosomal Protein Profiling for Detection of Cardiac Transplant Rejection
#95Method for Using a Marker Set for Determining the Risk of Kidney Rejection
#96ALX receptor ligands define a biochemical endotype for inflammation-based diseases
#97Methods for diagnosing risk of renal allograft fibrosis and rejection
#98Methods And Compositions For Noninvasive Detection Of Organ Transplant Rejection
#99Methods and materials for identifying and treating acute graft-versus-host disease
#100Biomarkers for graft-versus-host disease
#101Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#102Method of predicting graft versus host disease
#103METHODS FOR USING ENRICHED EXOSOMES AS A PLATFORM FOR MONITORING ORGAN STATUS
#104Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#105METHOD FOR PREDICTING ORGAN TRANSPLANT REJECTION USING NEXT-GENERATION SEQUENCING
#106Method and treating renal disease
#107Pharmaceutical composition comprising IL-34 and a mTOR inhibitor
#108Antigen presenting cell assay
#109COMPOSITIONS AND METHODS FOR DETECTING SLA REACTIVITY
#110Method for predicting and monitoring clinical response to immunomodulatory therapy
#111Methods and systems for analysis of organ transplantation
#112Use of immune repertoire diversity for predicting transplant rejection
#113Detection and quantification of donor cell-free DNA in the circulation of organ transplant recipients
#114Exosomal Protein Profiling for Detection of Cardiac Transplant Rejection
#115Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
#116MOLECULAR METHODS FOR ASSESSING POST KIDNEY TRANSPLANT COMPLICATIONS
#117Methods and compositions for the detection of Fc receptor binding activity of antibodies
#118METHOD TO DETECT BLOOD CREATININE AND AN IMMUNOSUPPRESSIVE DRUG
#119SUBPOPULATION OF CD8+CD45RCLOW TREGS AND USES THEREOF
#120METHOD FOR SELECTING A TRANSPLANTATION DONOR OR DONOR MATERIAL USING LOW OR INTERMEDIATE HLA TYPING INFORMATION
#121Methods and systems for predicting alloreactivity in transplantation
#122COMPOSITIONS AND METHODS FOR MODULATING PRO-INFLAMMATORY IMMUNE RESPONSE
#123METHOD FOR EVALUATION OF GRAFTS
#124Biomarkers for the detection of acute rejection in heart transplantation
#125Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma
#126CXCL10 AS PREDICTIVE BIOMARKER OF RENAL TRANSPLANT ACUTE REJECTION AND DIAGNOSTIC BIOMARKER OF ANTIBODY-MEDIATED REJECTION (ABMR)
#127Methods and kits for labeling, detection and isolation of Foxp3 regulatory T cells, isolated population of Foxp3 regulatory T cells thus obtained and uses thereof
#128INHIBITION OF AXL/GAS6 SIGNALING IN THE TREATMENT OF LIVER FIBROSIS
#129Attractin and lumican biomarkers in idiopathic pneumonia syndrome
#130METHOD TO DETECT THE ONSET AND TO MONITOR THE RECURRENCE OF CHRONIC GRAFT VERSUS HOST DISEASE IN TRANPLANTATION PATIENTS
#131Methods for diagnosing and reducing incidences of cardiac allograft rejection
#132TH17-PRONE CD146+CCR5+ T-CELL POPULATION AS AN EARLY MARKER OF INTESTINAL GRAFT-VERSUS-HOST DISEASE
#133T CELL-BOUND CYTOKINE ASSAY FOR ANTIGEN-SPECIFIC TOLERANCE
#134B-cell antigen presenting cell assay
#135Methods for treating patients at risk for costimulation blockade resistant rejection with belatacept
#136Antigen presenting cell assay
#137HLA G-modified cells and methods
#138Compositions and methods for detecting anti-endothelial cell antibodies in allograft rejection
#139Biomarkers and assay to detect chronic graft versus host disease
#140INTESTINAL MICROBIOTA AND GVHD
#141METHODS FOR DETECTING SINUSOIDAL OBSTRUCTIVE SYNDROME (SOS)
#142Methods and kits for screening transplant recipients and candidates
#143PROTEIN AND GENE BIOMARKERS FOR REJECTION OF ORGAN TRANSPLANTS
#144BIOMARKERS FOR ANDERSON-FABRY DISEASE
#145Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34
#146TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTION
#147Molecular signatures for distinguishing liver transplant rejections or injuries
#148Isolated donor MHC-derived peptide and uses thereof
#149A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION
#150Methods for diagnosing risk of renal allograft fibrosis and rejection
#151METHODS AND COMPOSITIONS FOR DIAGNOSING DISEASE
#152METHODS AND DEVICES FOR DIAGNOSING OCULAR SURFACE INFLAMMATION AND DRY EYE DISEASE
#153Devices and methods for the rapid and accurate detection of analytes
#154Portable instrument for in vitro detection and quantification of biomarkers
#155Method for detecting antibody-secreting B cells specific for HLA
#156ALLOGRAFT REJECTION TEST
#157Modified Fc gamma receptor type III (FCγIII, HNA-1) polypeptides and the uses thereof
#158Methods of predicting acute rejection outcomes
#159MATERIALS AND METHODS FOR DIAGNOSIS OF PERI-IMPLANT BONE AND JOINT INFECTIONS USING PROPHENOLOXIDASE PATHWAY
#160Protein biomarkers for immune assessment and prediction of transplant rejection
#161Isolated donor MHC-derived peptide and uses thereof
#162KIT FOR MONITORING, DETECTING AND STAGING GVHD
#163Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
#164Diagnostic and immunotherapy compositions and methods for disease states mediated by inhibitor-resistant CD8 T-cells
#165STAT3 phosphorylation during graft-versus-host disease
#166Biomarkers for determining an allograft tolerant phenotype
#167Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
#168Non-Invasive Biomarker of Antibody-Mediated Allograft Rejection
#169METHOD FOR DETERMINATION OF THE STATUS OF A DISEASE
#170BIOMARKERS AND USES THEREOF
#171METHODS FOR ASSAYING IMMUNOLOGICAL COMPETENCE
#172TETRASPANIN CD82 AS A DIAGNOSTIC AND/OR THERAPEUTIC MODULE FOR XENOGRAFT RECOGNITION AND/OR REJECTION
#173Method for preventing and treating renal disease
#174B-cell antigen presenting cell assay
#175Methods and kits for identifying effector Treg cells
#176TRACKING DONOR-REACTIVE TCR AS A BIOMARKER IN TRANSPLANTATION
#177METHODS FOR IDENTIFYING PATIENTS AT RISK FOR COSTIMULATION BLOCKADE RESISTANT REJECTION
#178RECEPTORS FOR B7-H4
#179Methods and compositions for diagnosing disease
#180MARKERS FOR LONG-TERM KIDNEY GRAFT DYSFUNCTION
#181Systems and methods for characterizing kidney diseases
#182Compositions And Methods For Heparan Sulfate As A Biomarker For Transplant Rejection
#183In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant, a neurodegenerative disorder or a depression
#184Parasitic biological agents for treatment and prevention of graft versus host disease
#185Use of ACY-1 as a marker of ischaemia/reperfusion, delayed graft function and graft viability as well as method thereof
#186Use of SHROOM3 in chronic kidney disease and chronic allograft nephropathy
#187Detection of free and protein-bound non-human gal-alpha(1-3)-gal epitope
#188Methods for determining risk of chronic lung allograft dysfunction (CLAD) and subtypes thereof
#189Methods and compositions for assessing lung grafts
#190Methods for determining the risk of acute graft versus host disease
#191Method for prediction of an immune response against mismatched human leukocyte antigens
#192LYVE-1 ANTAGONISTS FOR PREVENTING OR TREATING A PATHOLOGICAL CONDITION ASSOCIATED WITH LYMPHANGIOGENESIS
#193Substances, vaccines and methods for diagnosing and reducing incidences of transplant rejection
#194PRE-TRANSPLANT IgG REACTIVITY TO APOPTOTIC CELLS CORRELATES WITH LATE KIDNEY ALLOGRAFT LOSS
#195SPECIFIC REMOVAL OF ACTIVATED IMMUNE CELLS
#196Screening methods for transfusion related acute lung injury (TRALI)
#197METHODS FOR DETERMINING WHETHER A CYTOMEGALOVIRUS INFECTION IN A TRANSPLANTED PATIENT IS SUCEPTIBLE TO INDUCE ALLOGRAFT REJECTION
#198ANTI-PRO87299 ANTIBODIES
#199Identification of New Therapeutic Uses for Known Therapeutic Agents
#200Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
#201POLYPEPTIDE MARKERS FOR THE EARLY RECOGNITION OF THE REJECTION OF TRANSPLANTED KIDNEYS
#202ENDOTHELIAL CELLS ACTIVATION BIOMARKERS CHARACTERIZING ANTIBODY MEDIATED REJECTION AND USES THEREOF
#203Compositions and methods for the detection of antibodies to native human leukocyte antigen
#204THERAPEUTIC STRATEGY FOR TREATING AUTOIMMUNE AND DEGENERATIVE DISEASES
#205PGLYRP2 biomarker in idiopathic pneumonia syndrome
#206MEANS AND METHODS FOR DIAGNOSTICS AND THERAPEUTICS OF DISEASES
#207Methods and compositions for diagnosing disease
#208Kit for monitoring immune status after transplant and method for monitoring immune status using same
#209Volatile Organic Gases as Bioindicators for Transplant Rejection
#210BIOTINYLATED MHC COMPLEXES AND THEIR USES
#211Method and reagent for diagnosis and/or evaluation of progression of graft-versus-host disease
#212Method to detect the onset and to monitor the recurrence of chronic graft versus host disease in transplantation patients
#213Use of an anti-CD200 antibody for prolonging the survival of allografts
#214Methods of detecting antibodies specific for denatured HLA antigens
#215Antigen presenting cell assay
#216Assessment and reduction of risk of graft-versus-host disease
#217Method for evaluating regenerated cartilage
#218METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#219Systems and methods for determining antibody-mediated risk index
#220Assays, methods and kits for predicting renal disease and personalized treatment strategies
#221Anti-CD80 antibody
#222Screening methods for transfusion related acute lung injury (TRALI)
#223Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis
#224Method and system for evaluation of grafts
#225Protein and gene biomarkers for rejection of organ transplants
#226Anti-CD74 immunoconjugates and methods of use
#227Methods for detecting graft-versus-host disease
#228METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#229B-cell antigen presenting cell assay
#230HMG1 antibody for treating inflammatory conditions
#231Methods and compositions to predict and detect acute rejection
#232Anti-LG3 antibodies and uses thereof
#233Biomarkers for determining an allograft tolerant phenotype
#234System and Method for Detecting and Quantifying Active T-cells or Natural Killer Cells
#235Biomarkers for the Diagnosis of Kidney Graft Rejection
#236Assay for Soluble CD200
#237Detection of B-cell activating factor as a biomarker for antibody mediated rejection in transplant recipients
#238METHOD OF ASSESSING ISLET FUNCTION
#239STIMULATORY AUTO-ANTIBODIES TO THE PDGF RECEPTOR AS PATHOLOGY MARKER AND THERAPEUTIC TARGET
#240Monoclonal antibody against human HIG-1 polypeptide
#241RANTES LEVELS AS A DIAGNOSTIC AND THERAPEUTIC FOR ACUTE GRAFT VERSUS HOST DISEASE
#242BIOMARKERS FOR PROGNOSES OF PULMONARY DISEASES
#243TISSUE REJECTION
#244ASSAY METHOD AND DEVICE
#245Systems and methods for characterizing kidney diseases
#246RAPID SACCHARIDE BIOMARKER ASSAY
#247METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERS
#248Measurement of Mitochondrial Membrane Potential to Assess Organ Dysfunction
#249Anti-PRO87299 Antibodies
#250Methods for Monitoring Allograft Rejection
#251Semi-Invasive Method for Characterizing Lung Injury
#252Methods of administering PIF agonist peptides and uses thereof
#253Anti-CD74 immunoconjugates and methods of use
#254Compartment-Specific Non-HLA Targets for Diagnosis and Prediction of Graft Outcome
#255Method for identifying idiopathic pneumonia progression by measuring the level of mannose-binding protein C
#256Anti-CD86 antibody
#257METHOD TO DEPLETE MONOCLONAL ANTIBODIES IN A BIOLOGICAL SAMPLE
#258Screening methods for transfusion related acute lung injury
#259Markers of renal transplant rejection and renal damage
#260BIOMARKERS AND USES THEREOF
#261Biomarkers for the Diagnosis of Renal Allograft and Kidney Status
#262Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
#263Method for Determining the Cbl-b Expression
#264Methods of treatment using antibodies to Neutrokine-alpha
#265BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS
#266Serum Biomarkers For Early Detection Of Acute Cellular Rejection
#267METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK
#268Graft-versus-host disease predicting marker and use thereof
#269Method for Evaluating Immunosuppression
#270Blood group antigens of different types for diagnostic and therapeutic applications
#271Methods of detecting antibodies specific for denatured HLA antigens
#272Biomarkers for lung disease monitoring
#273METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
#274Healthy kidney biomarkers
#275BLOOD MARKERS OF TRANSPLANTED INTESTINE REJECTION
#276Compositions and methods for the detection of antibodies to native human leukocyte antigen
#277METHODS OF DIAGNOSING CHRONIC CARDIAC ALLOGRAFT REJECTION
#278Methods of Diagnosing Rejection of a Kidney Allograft Using Genomic or Proteomic Expression Profiling
#279PREDICTING AND REDUCING ALLOIMMUNOGENICITY OF PROTEIN THERAPEUTICS
#280Use application of sugar chain-recognizing receptor
#281Marker for graft failure and mortality
#282METHODS AND REAGENTS FOR DETECTING SUSCEPTIBILITY TO GRAFT VERSUS HOST DISEASE OR TRANSPLANT RELATED MORTALITY
#283METHODS OF DIAGNOSING ACUTE CARDIAC ALLOGRAFT REJECTION
#284IN VITRO DIAGNOSIS/PROGNOSIS METHOD AND KIT FOR ASSESSMENT OF TOLERANCE IN LIVER TRANSPLANTATION
#285Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration
#286Anti-CD74 immunoconjugates and methods
#287IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57
#288Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
#289Assay for soluble CD200
#290NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#291METHOD OF IMMUNOLOGICAL ANALYSIS FOR DETECTION OF ANTIBODIES AGAINST HUMAN GSTT1 (ANTI-HGSTT1)
#292PROGNOSTIC ASSAY FOR DETERMINING T CELL RESPONSE TO HLA ANTIGENS AND USE THEREOF IN FIELD OF TISSUE TRANSPLANTATION
#293HEMATOPOIETIC CELLS EXPRESSING THE PROTEIN SUSD3 AND LIGANDS FOR THE PROTEIN SUSD3
#294Granulysin and uses thereof
#295Determining whether a test compound modulates PD-1 activity in activated immune cells using gene expression profiles
#296METHODS OF TREATMENT USING ANTIBODIES TO NEUTROKINE-ALPHA
#297HUMANIZED ANTI-HUMAN CD34 ANTIBODY, THE PREPARATION METHOD AND USES THEREOF
#298B CELL SIGNATURE ASSOCIATED WITH TOLERANCE IN TRANSPLANT RECIPIENTS
#299METHODS AND KITS FOR DIAGNOSIS AND/OR PROGNOSIS OF THE TOLERANT STATE IN LIVER TRANSPLANTATION
#300ASSESSING TISSUE REJECTION